173 related articles for article (PubMed ID: 19447890)
1. Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.
Zhou J; Feng X; Ban B; Liu J; Wang Z; Xiao W
J Biol Chem; 2009 Jul; 284(28):19142-52. PubMed ID: 19447890
[TBL] [Abstract][Full Text] [Related]
2. The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
Pascual-Le Tallec L; Simone F; Viengchareun S; Meduri G; Thirman MJ; Lombès M
Mol Endocrinol; 2005 May; 19(5):1158-69. PubMed ID: 15650021
[TBL] [Abstract][Full Text] [Related]
3. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.
Xiao W; Jiang F; Wang Z
Prostate; 2006 Jan; 66(1):1-12. PubMed ID: 16114057
[TBL] [Abstract][Full Text] [Related]
4. The amino-terminal domain of ELL transcription elongation factor is essential for ELL function in Schizosaccharomyces pombe.
Sweta K; Dabas P; Jain K; Sharma N
Microbiology (Reading); 2017 Nov; 163(11):1641-1653. PubMed ID: 29043956
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL.
Wiederschain D; Kawai H; Gu J; Shilatifard A; Yuan ZM
Mol Cell Biol; 2003 Jun; 23(12):4230-46. PubMed ID: 12773566
[TBL] [Abstract][Full Text] [Related]
7. Sequence, structural and functional conservation among the human and fission yeast ELL and EAF transcription elongation factors.
Sweta K; Dabas P; Sharma N
Mol Biol Rep; 2022 Feb; 49(2):1303-1320. PubMed ID: 34807377
[TBL] [Abstract][Full Text] [Related]
8. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
[TBL] [Abstract][Full Text] [Related]
10. Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.
Cai L; Phong BL; Fisher AL; Wang Z
J Biol Chem; 2011 Oct; 286(41):35915-35921. PubMed ID: 21880729
[TBL] [Abstract][Full Text] [Related]
11. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F; Ai J; Xiao W; Wang Z
Cancer Lett; 2007 Aug; 253(2):265-72. PubMed ID: 17395368
[TBL] [Abstract][Full Text] [Related]
12. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
Simone F; Luo RT; Polak PE; Kaberlein JJ; Thirman MJ
Blood; 2003 Mar; 101(6):2355-62. PubMed ID: 12446457
[TBL] [Abstract][Full Text] [Related]
13. Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53.
Shinobu N; Maeda T; Aso T; Ito T; Kondo T; Koike K; Hatakeyama M
J Biol Chem; 1999 Jun; 274(24):17003-10. PubMed ID: 10358050
[TBL] [Abstract][Full Text] [Related]
14. The Tax oncogene enhances ELL incorporation into p300 and P-TEFb containing protein complexes to activate transcription.
Fufa TD; Byun JS; Wakano C; Fernandez AG; Pise-Masison CA; Gardner K
Biochem Biophys Res Commun; 2015 Sep; 465(1):5-11. PubMed ID: 26188510
[TBL] [Abstract][Full Text] [Related]
15. ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1.
Zhang W; Ji W; Liu X; Ouyang G; Xiao W
Mol Cell Biol; 2014 Feb; 34(4):765-75. PubMed ID: 24344198
[TBL] [Abstract][Full Text] [Related]
16. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
17. ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.
Liu L; Ai J; Xiao W; Liu J; Wang Y; Xin D; He Z; Guo Y; Wang Z
Prostate; 2010 May; 70(7):797-805. PubMed ID: 20166137
[TBL] [Abstract][Full Text] [Related]
18. Structure function characterization of the ELL Associated Factor (EAF) from Schizosaccharomyces pombe.
Dabas P; Sweta K; Ekka M; Sharma N
Gene; 2018 Jan; 641():117-128. PubMed ID: 29032152
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex.
Shilatifard A; Haque D; Conaway RC; Conaway JW
J Biol Chem; 1997 Aug; 272(35):22355-63. PubMed ID: 9268387
[TBL] [Abstract][Full Text] [Related]
20. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
Thirman MJ; Levitan DA; Kobayashi H; Simon MC; Rowley JD
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12110-4. PubMed ID: 7991593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
